Protective effect of radicicol against LPS/IFN-γ-induced neuronal cell death in rat cortical neuron-glia cultures

Life Sciences

Volumn 80, Issue 18, 2007, Pages 1706-1712

  Sohn, Mi Jin ^a   Noh, Hyun Jeong ^a   Yoo, Ick Dong ^a   Kim, Won Gon ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Glia mediated neurotoxicity; Inducible nitric oxide synthase; Microglia; Radicicol; Tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; RADICICOL; TUMOR NECROSIS FACTOR ALPHA;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; BRAIN CELL; CELL CULTURE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; DRUG POTENCY; EMBRYO; GLIA; INFLAMMATION; MICROGLIA; NEURITE; NEUROTOXICITY; NONHUMAN; RAT;

ANIMALS; ANTIBIOTICS, ANTIFUNGAL; CELL DEATH; CELLS, CULTURED; CEREBELLAR CORTEX; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MACROLIDES; NEUROGLIA; NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 33947317935     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.01.054     Document Type: Article

References (36)

1. Askalan R., Deveber G., Ho M., Ma J., and Hawkins C. Astrocytic-inducible nitric oxide synthase in the ischemic developing human brain. Pediatric Research 60 6 (2006) 687-692
2. Beliakoff J., and Whitesell L. HSP90: an emerging target for breast cancer therapy. Anticancer Drugs 15 7 (2004) 651-662
3. Block M.L., and Hong J.-S. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Progress in Neurobiology 76 (2005) 77-98
4. Bronstein D.M., Perez-Otano I., Sun V., Mullis Sawin S.B., Chan J., Wu G.-C., Hudson P.M., Kong L.-Y., Hong J.-S., and McMillian M.K. Glia dependent neurotoxicity and neuroprotection in mesencephalic cultures. Brain Research 704 1 (1995) 112-116
5. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., and Peterson P.K. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. Journal of Immunology 149 8 (1992) 2736-2741
6. Combs C.K., Johnson D.E., Karlo J.C., Cannady S.B., and Landreth G.E. Inflammatory mechanism in Alzheimer's disease: inhibition of β-amyloid-stimulated proinflammatory response and neurotoxicity by PPARγ agonists. Journal of Neurosience 20 2 (2000) 558-567
7. Craft J.M., Watterson D.M., and Van Eldik L.J. Human amyloid β-induced neuroinflammation is early event in neurodegeneration. Glia 53 5 (2006) 484-490
8. Culbert A.A., Skaper S.D., Howlett D.R., Evans N.A., Facci L., Soden P.E., Seymour Z.M., Guillot F., Gaestel M., and Richardson J.C. MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity: relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease. Journal of Biological Chemistry 281 33 (2006) 23658-23667
9. Dawson V.L., Brahmbhatt H.P., Mong J.A., and Dawson T.M. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. Neurophamacology 33 11 (1994) 1425-1430
10. Galea-Lauri J., Richardson A.J., Latchman D.S., and Katz D.R. Increased heat shock protein 90(hsp90) expression leads to increased apoptosis in the monoblastoid cell line U937 following induction with TNF-α and cycloheximide. Journal of Immunology 157 9 (1996) 4109-4118
11. 15N] nitrate in biological fluids. Analytical Biochemistry 126 1 (1982) 131-138
12. Hsiao H.-Y., Mak O.-T., Yang C.-S., Liu Y.-P., Fang K.-M., and Tzeng S.-F. TNF-α/IFN-γ-induced iNOS expression increased by prostaglandin E2 in rat primary astrocytes via EP2-evoked cAMP/PKA and intracellular calcium signaling. Glia 55 2 (2007) 214-223
13. Ii M., Sunamoto M., Ohnishi K., and Ichimori Y. β-amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity. Brain Research 720 1-2 (1996) 93-100
14. Jeohn G.-H., Wilson B., Wetsel W.C., and Hong J.-S. The indolocarbazole Gö 6976 protects neurons from lipopolysaccharide/interferon-γ-induced cytotoxicity in murine neuron/glia co-cultures. Molecular Brain Research 79 1-2 (2000) 32-44
15. Jeon Y.J., Kim Y.K., Lee M., Park S.M., Han S.B., and Kim H.M. Radicicol suppresses expression of inducible nitric-oxide synthase by blocking p38 kinase and nuclear factor-κB/Rel in lipopolysaccharide-stimulated macrophages. Journal of Pharmacology and Experimental Therapeutics 294 2 (2000) 548-554
16. Kim W.-G., Mohney R.P., Wilson B., Jeohn G.-H., Bin L., and Hong J.-S. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain; role of microglia. The Journal of Neuroscience 20 16 (2000) 6309-6316
17. Kim Y.-J., Hwang S.-Y., Oh E.-S., Oh S., and Han I.-O. IL-1β, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-κB pathways. Journal of Neuroscience Research 84 5 (2006) 1037-1046
18. Kong L.-Y., McMillian M.K., Maronport R., and Hong J.-S. Protein tyrosine kinase inhibitors suppress the production of nitric oxide in mixed glia, microglia-enriched or astrocyte-enriched cultures. Brain Research 729 1 (1996) 102-109
19. Kwon H.J., Yoshida M., Fukui Y., Horinouchi S., and Beppu Y. Potent and specific inhibition of p60v-src protein kinase both in vivo and in vitro by radicicol. Cancer Research 52 24 (1992) 6926-6930
20. Kwon H.J., Yoshida M., Muroya K., Hattori S., Nishida E., Fukui Y., Beppu Y., and Horinouchi S. Morphology of ras-transformed cells becomes apparently normal again with tyrosine kinase inhibitors without a decrease in the Ras-GTP complex. Journal of Biochemistry (Tokyo) 118 (1995) 221-228
21. Lee S.C., Liu W., Dickson D.W., Brosnan C.F., and Berman J.W. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1β. Journal of Immunology 150 7 (1993) 2659-2667
22. Liu B., Du L., and Hong J.S. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. Journal of Pharmacology and Experimental Therapeutics 293 2 (2000) 607-617
23. Maloney A., and Workman P. HSP90 as a new therapeutic targets cancer therapy: the story unfolds. Expert Opinion on Biological Therapy 2 1 (2002) 3-24
24. McCapra F., McCapra F., Scott A.I., Delmotte P., Delmotte-Plaquee J., and Bhacca N.S. The constitution of monorden, an antibiotic with tranquilizing action. Tetrahedron Letters 5 15 (1964) 869-875
25. McGeer P.L., Itagaki S., Boyes B.E., and McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38 8 (1998) 1285-1291
26. Na Y.J., Jeon Y.J., Suh J.H., Kang J.S., Yang K.H., and Kim H.M. Suppression of IL-8 gene expression by radicicol is mediated through the inhibition of ERK1/2 and p38 signalling and negative regulation of NF-κB and AP-1. International Immunopharmacology 1 9-10 (2001) 1877-1887
27. Ohtsuki T., Matsumoto M., Kitagawa K., Mabuchi T., Mandai K., Matsusita K., Kuwabara K., Tagaya M., Ogawa S., Ueda H., Kamada T., and Yanagihara T. Delayed neuronal death in ischemic hippocampus involves stimulation of protein tyrosine phosphorylation. American Journal of Physiology 271 4 (1996) 1085-1097
28. Possel H., Noack H., Putzke J., Wolf G., and Sies H. Selective upregulation of inducible nitric oxide synthase (iNOS) by lipopolysaccharide 9LPS) and cytokines in microglia: in vitro and in vivo studies. Glia 32 1 (2000) 51-59
29. Raine C.S. Multiple sclerosis: immune system molecule expression in the central nervous system. Journal Neuropathology and Experimental Neurolology 53 4 (1994) 328-337
30. Ralay Ranaivo H., Craft J.M., Hu W., Guo L., Wing L.K., Van Eldik L.J., and Watterson D.M. Glia as a therapeutic target: selective suppression of human amyloid-β-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration. Journal of Neuroscience 26 2 (2006) 662-670
31. Roe S.M., Prodromou C., O'Brien R., Ladbury J.E., Piper P.W., and Pearl L.H. Structural basis for inhibition of Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. Journal of Medicinal Chemistry 42 2 (1999) 260-266
32. Sano M. Radicicol and geldanamycin prevent neurotoxic effects of anti-cancer drugs on cultured embryonic sensory neurons. Neuropharmacology 40 4 (2001) 947-953
33. Sharma S.V., Agatsuma T., and Nakano H. Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol. Oncogene 16 20 (1998) 2639-2645
34. Shino Y., Fujita Y., Oka S., and Yamazaki Y. ATPase inhibitors suppress actinomycin D-induced apoptosis in leukemia cells. Anticancer Research 22 5 (2002) 2907-2911
35. Soga S., Neckers L.M., Schulte T.W., Shiotsu Y., Akasaka K., Narumi H., Agatsuma T., Ikuina Y., Murakata C., Tamaoki T., and Akinaga S. KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules. Cancer Research 59 12 (1999) 2931-2938
36. Streit W.J., Conde J.R., Fendrick S.E., Flanary B.E., and Mariani C.L. Role of microglia in the central nervous system's immune response. Neurological Research 27 7 (2005) 685-691